Combination of Buffered Anesthetic to Treat Mandibular Molars

• Status: Recruiting
• Trial end date: 2024-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a combination of anesthetics (numbing medicine) will adequately anesthetize teeth over a different combination. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Indiana University
• Treatments: Carticaine; Epinephrine; Epinephryl borate; Lidocaine; Mepivacaine; Racepinephrine

Criteria

Inclusion Criteria:

• Be between the ages of 18 and 80 years old

• Have the ability and willingness to independently consent to treatment and study participation

• Have an uncomplicated medical history (ASA I and II)

• Not be pregnant

• Have no allergies local anesthetics/sulfites (confirmed or self-reported)

• Not be taking any medications that may affect the proper assessment of the anesthetic (no acetaminophen or short-acting NSAIDs such as ibuprofen within the previous 6 hours; no long-acting NSAIDs such as naproxen within the previous 16 hours)

• Not require nitrous oxide during treatment, and the injection area should appear healthy with no other pre-existing conditions or infections that may compromise an accurate collection of data

• Be experiencing signs of irreversible pulpitis (an exaggerated response to cold that lingers longer than 10 seconds) in a mandibular molar at the time of conducting the study

Exclusion Criteria:

• A negative response to cold in the proposed treatment tooth

• A radiographic periradicular pathosis more advanced than a widened periodontal ligament or have an intraoral swelling